Results 191 to 200 of about 883,016 (338)

A case of intestinal Behcet’s disease under Adalimumab

open access: diamond, 2017
David Dulaney   +3 more
openalex   +2 more sources

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky   +8 more
wiley   +1 more source

Lipocalin-2 and intestinal diseases. [PDF]

open access: yesWorld J Gastroenterol
Zhang ZX, Peng J, Ding WW.
europepmc   +1 more source

High Concordance of CT Colonography and Colonoscopy Allows for the Distinguishing and Diagnosing of Intestinal Diseases. [PDF]

open access: yesLife (Basel), 2023
Chervenkov L   +7 more
europepmc   +1 more source

Prognostic Implications of Sleep Architecture for Patients Admitted to the Intensive Care Unit With Status Epilepticus

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Status epilepticus (SE) is associated with significant mortality. Sleep architecture may reflect normal brain function. Impaired sleep architecture is associated with poorer outcomes in numerous conditions. Here we investigate the association of sleep architecture in continuous EEG (cEEG) with survival in SE.
Ran R. Liu   +5 more
wiley   +1 more source

The emerging roles of bacterial proteases in intestinal diseases. [PDF]

open access: yesGut Microbes, 2023
Caminero A   +3 more
europepmc   +1 more source

New-onset impulse control disorders after treatment with levodopa–carbidopa intestinal gel in Parkinson's disease

open access: gold, 2023
A. Contreras Chicote   +3 more
openalex   +1 more source

Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones   +3 more
wiley   +1 more source

Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells

open access: yesSignal Transduction and Targeted Therapy, 2022
Guang Chen   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy